Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Mauro Loi"'
Autor:
Davide Franceschini, Mauro Loi, Antonio Marco Marzo, Luca Dominici, Ruggero Spoto, Anna Bertolini, Lorenzo Lo Faro, Francesco La Fauci, Beatrice Marini, Luciana Di Cristina, Marta Scorsetti
Publikováno v:
Diseases, Vol 12, Iss 7, p 153 (2024)
Few data are available on the role of SBRT re-irradiation for isolated recurrences. We designed a prospective phase I study to evaluate the maximum tolerated dose (MTD) of SBRT for thoracic re-irradiation, for peripheral lung lesions. RT was delivere
Externí odkaz:
https://doaj.org/article/2d8c8eec0ec840f38511a8effbefb919
Autor:
Milovan Savanović, Bojan Štrbac, Dražan Jaroš, Mauro Loi, Florence Huguet, Jean-Noël Foulquier
Publikováno v:
Journal of Biomedical Physics and Engineering, Vol 13, Iss 1, Pp 65-76 (2023)
Background: Mobility of lung tumors is induced by respiration and causes inadequate dose coverage. Objective: This study quantified lung tumor motion, velocity, and stability for small (≤5 cm) and large (>5 cm) tumors to adapt radiation therapy tec
Externí odkaz:
https://doaj.org/article/374541c27c8d4123bde7e3bb29a22fe1
Autor:
Tiziana Comito, Mauro Loi, Ciro Franzese, Elena Clerici, Davide Franceschini, Marco Badalamenti, Maria Ausilia Teriaca, Lorenza Rimassa, Vittorio Pedicini, Dario Poretti, Luigi Alessandro Solbiati, Guido Torzilli, Roberto Ceriani, Ana Lleo, Alessio Aghemo, Armando Santoro, Marta Scorsetti
Publikováno v:
Current Oncology, Vol 29, Iss 11, Pp 8802-8813 (2022)
Background: Hepatocellular carcinoma (HCC) is the most frequent liver malignancy and a leading cause of cancer death in the world. In unresectable HCC patients, transcatheter arterial (chemo-) embolization (TAE/TACE) has shown a disease response in 1
Externí odkaz:
https://doaj.org/article/3952ea917853480d816d006a980d5279
Autor:
Icro Meattini, Giulio Francolini, Vanessa Di Cataldo, Luca Visani, Carlotta Becherini, Erika Scoccimarro, Viola Salvestrini, Chiara Bellini, Laura Masi, Raffaela Doro, Federica Di Naro, Mauro Loi, Giulia Salvatore, Gabriele Simontacchi, Daniela Greto, Marco Bernini, Jacopo Nori, Lorenzo Orzalesi, Simonetta Bianchi, Monica Mangoni, Lorenzo Livi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 94-100 (2022)
Background and purpose: Preoperative partial breast irradiation (PBI) has got the advantage of treating a well-defined target. We report the results of the phase II ROCK trial (NCT03520894), enrolling early breast cancer (BC) patients treated with pr
Externí odkaz:
https://doaj.org/article/8f1bd43896684de4ba97c8b20e6dd6fb
Autor:
Ilaria Morelli, Carlotta Becherini, Marco Banini, Marianna Valzano, Niccolò Bertini, Mauro Loi, Giulio Francolini, Icro Meattini, Viola Salvestrini, Pierluigi Bonomo, Lorenzo Livi, Isacco Desideri
Publikováno v:
Applied Sciences, Vol 13, Iss 23, p 12942 (2023)
Background: Oropharyngeal Squamous Cell Carcinoma (OPSCC) is rapidly increasing due to the spread of Human Papillomavirus (HPV) infection. HPV-positive disease has unique characteristics, with better response to treatment and consequent better progno
Externí odkaz:
https://doaj.org/article/e4198cd12a014323a5a9c2d90a673275
Autor:
Luca Nicosia, Davide Franceschini, Francesca Perrone-Congedi, Alessandro Molinari, Marianna Alessandra Gerardi, Michele Rigo, Rosario Mazzola, Marco Perna, Vieri Scotti, Andrei Fodor, Aurelia Iurato, Francesco Pasqualetti, Giovanni Gadducci, Silvia Chiesa, Rita Marina Niespolo, Alessio Bruni, Anna Cappelli, Elisa D'Angelo, Paolo Borghetti, Alessandro Di Marzo, Andrea Ravasio, Berardino De Bari, Matteo Sepulcri, Dario Aiello, Gianluca Mortellaro, Claudia Sangalli, Marzia Franceschini, Giampaolo Montesi, Francesco Maria Aquilanti, Gianluigi Lunardi, Riccardo Valdagni, Ivan Fazio, Giovanni Scarzello, Vittorio Vavassori, Ernesto Maranzano, Stefano Maria Magrini, Stefano Arcangeli, Maria Antonietta Gambacorta, Vincenzo Valentini, Fabiola Paiar, Sara Ramella, Nadia Gisella Di Muzio, Mauro Loi, Barbara Alicja Jereczek-Fossa, Franco Casamassima, Mattia Falchetto Osti, Marta Scorsetti, Filippo Alongi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100568- (2023)
Aim: Stereotactic ablative radiotherapy (SABR) showed increasing survival in oligometastatic patients. Few studies actually depicted oligometastatic disease (OMD) evolution and which patient will remain disease-free and which will rapidly develop a p
Externí odkaz:
https://doaj.org/article/12bd891409d0457cba1efe908e48a2d5
Autor:
Mauro Loi, Giulia Salvatore, Michele Aquilano, Daniela Greto, Cinzia Talamonti, Viola Salvestrini, Maria Elena Melica, Marianna Valzano, Giulio Francolini, Mariangela Sottili, Costanza Santini, Carlotta Becherini, Domenico Andrea Campanacci, Monica Mangoni, Lorenzo Livi
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 22, p 14305 (2022)
Trabectedin is used for the treatment of advanced soft tissue sarcomas (STSs). In this study, we evaluated if trabectedin could enhance the efficacy of irradiation (IR) by increasing the intrinsic cell radiosensitivity and modulating tumor micro-envi
Externí odkaz:
https://doaj.org/article/04fbe55788a8433a94004161c664547c
Autor:
Christophe Klein, Diane Damotte, Alexandra Leary, Adrien Joseph, Sebastien Gouy, Marco Alifano, Marie-Caroline Dieu-Nosjean, Guido Kroemer, Eric Deutsch, Antoine Lafarge, Philippe Morice, Julien Adam, Patricia Pautier, Cyrus Chargari, Isabelle Cremer, Catherine Genestie, Pan Juncheng, Michele Mondini, Nizar Labaied, Mauro Loi, Valentina Astesana, Florine Obrist, Norma Bloy, Gautier Stoll, Nicolas Signolle, Maria Castedo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Background Tumors rewire their metabolism to achieve robust anabolism and resistance against therapeutic interventions like cisplatin treatment. For example, a prolonged exposure to cisplatin causes downregulation of pyridoxal kinase (PDXK), the enzy
Externí odkaz:
https://doaj.org/article/23e58e9d7ee549c68bea1e307cd90c73
Autor:
Luca Cozzi PhD, Tiziana Comito MD, Mauro Loi MD, Antonella Fogliata MSc, Ciro Franzese MD, Davide Franceschini MD, Elena Clerici MD, Giacomo Reggiori MSC, Stefano Tomatis MSc, Marta Scorsetti MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Purpose: To investigate the role of intensity-modulated proton therapy (IMPT) for hepatocellular carcinoma (HCC) patients to be treated with stereotactic body radiation therapy (SBRT) in a risk-adapted dose prescription regimen. Methods: A cohort of
Externí odkaz:
https://doaj.org/article/5d96efbb5e91462794a6763845b096c0
Autor:
Isacco Desideri, Mauro Loi, Giulio Francolini, Carlotta Becherini, Lorenzo Livi, Pierluigi Bonomo
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Normal tissue complication probability (NTCP) models that were formulated in the Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) are one of the pillars in support of everyday’s clinical radiation oncology. Because of steady t
Externí odkaz:
https://doaj.org/article/f8603462692d409cbd9382139883f15b